Search clinical trials for: Phentermine/Topiramate (Qsymia)

Total 398 results

University of Minnesota

Recruiting

Role of Pharmacotherapy in Counteracting Weight Regain in Adolescents With Severe Obesity

Obesity

United States
University of Minnesota

Recruiting

Phentermine/Topiramate in Adolescents With Type 2 Diabetes and Obesity

Pediatric Obesity

United States
Mayo Clinic
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Peripheral Pharmacodynamics of Phentermine-Topiramate in Obese Patients

Obesity

United States
Wake Forest University Health Sciences
VIVUS LLC

Completed

Qsymia as an Adjunct to Surgical Therapy in the Superobese

Obesity | Weight Loss | Metabolic Surgery | Bariatric Surgery Procedures

United States
Stanford University

Completed

FDA Approved Medication to Reduce Binge Eating and/or Purging

Bulimia Nervosa | Binge Eating Disorder

United States
Denver Health and Hospital Authority

Completed

A Toolbox Approach to Obesity Treatment in Primary Care (Toolbox)

Obesity

United States
VIVUS LLC

Completed

A Study of VI-0521 on Ambulatory Blood Pressure in Overweight or Obese Subjects

Blood Pressure

United States
Mayo Clinic

Completed

Anti-Obesity Phentermine-Topiramate Extended Release Pharmacotherapy vs Placebo Among Patients Using a Wearable Activity Tracker

Obesity

United States
Seattle Children's Hospital
Children's Hospital of Philadelphia

Not yet recruiting

Efficacy and Safety of Phentermine/Topiramate in Youth With Hypothalamic Obesity

Craniopharyngioma | Hypothalamic Obesity | Hypothalamic Tumor

United States
VIVUS LLC

Completed

Effect of VI-0521 (Qsymia®) on Glomerular Filtration Rate (GFR) in Overweight or Obese Healthy Subjects

Obesity

United States
VIVUS LLC

Completed

A Phase IV Safety and Efficacy Study of VI-0521 in Adolescents With Obesity

Adolescent Obesity | Obesity in Adolescence | Adolescent Overweight

United States
University of California, San Diego

Recruiting

Pharmacologic Weight Loss as Adjunct Therapy for Ulcerative Colitis in Obese Patients

Obesity | Colitis, Ulcerative

United States
VIVUS LLC
Synteract, Inc.; Sentrx

Completed

A VI-0521 Study to Evaluate the Long-term Safety and Efficacy in Type 2 Diabetic Adults

Diabetes

United States
VIVUS LLC
Covance; Sentrx

Completed

A Study to Evaluate the Pharmacokinetics of VI-0521 in Subjects With Hepatic Impairment

Hepatic Impairment

United States
VIVUS LLC
Medpace, Inc.

Completed

A Study Comparing Multiple Doses of VI-0521 With Placebo and Their Single-agent Constituents for Treatment of Obesity in Adults

Obesity

United States
University of Minnesota
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Active, not recruiting

SMART Use of Medication for the Treatment of Adolescent Severe Obesity (SMART)

Adolescent Obesity

United States
VIVUS LLC

Completed

Pharmacokinetic Comparison of Multiple Formulations of Topiramate and Phentermine in Obese Adults

Obesity

United States
VIVUS LLC
Medpace, Inc.

Completed

Study of VI-0521 Compared to Placebo in Treatment of Obesity in Adults

Obesity

United States
Alvogen Korea

Completed

Phase IV Study of Qsymia in Obese Patients

Obesity

Korea, Republic of
Medical College of Wisconsin

Recruiting

Risk of Metabolic Adaptation After Weight Loss

Obesity | Weight Loss

United States
VIVUS LLC

Completed

A Pharmacokinetic Study Comparing VI-0521 With Placebo in Obese Adolescents

Pediatric Obesity | Childhood Obesity

United States
VIVUS LLC

Completed

A Study to Evaluate the Pharmacokinetics of VI-0521 Subjects With Renal Impairment

Renal Impairment

United States
Jaime Moore, MD MPH
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University... and other collaborators

Completed

Adjunct Phentermine + Topiramate After Bariatric Surgery in 12-24 Year Olds

Adolescent | Obesity, Morbid | Drug Therapy | Bariatric Surgery | Young Adult

United States
Eisai Inc.

Completed

A Multicenter, Double-blind, Randomized, Parallel-group, Pilot Study of 12-week Duration to Assess the Short-term Safety and Tolerability of Lorcaserin Plus Two Doses of Immediate-Release Phentermine-HCl Compared With Lorcaserin Alone in Overweight and Obese Adults

Chronic Weight Management

United States
University of Florida
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

Obesity and Uric Acid Stones Study

Obesity | Type 2 Diabetes Mellitus in Obese | Pre-Diabetes | Uric Acid Stones

United States
Mayo Clinic

Completed

Individualized Obesity Pharmacotherapy

Obesity

United States
Woman's
AstraZeneca

Completed

EQW, DAPA, EQW/DAPA, DAPA/MET ER and PHEN/TPM ER in Obese Women With PolycysticOvary Syndrome (PCOS)

Obesity | Polycystic Ovary Syndrome

United States
Novo Nordisk A/S

Active, not recruiting

A Research Study Comparing Wegovy to Other Weight Management Drugs in People Living With Obesity in America

Obesity

United States
Johnson & Johnson Taiwan Ltd

Completed

First Add-on vs. Mono-therapy Study of Topiramate in Neuro-Surgical Patients (TEAMS)

Epilepsy
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Phase 1 Bioavailability Study of Topiramate Oral Liquid Formulation Compared to the Marketed Sprinkle Capsule Formulation in Healthy Adults

Epilepsy
Supernus Pharmaceuticals, Inc.

Completed

A Conversion Study of Immediate Release (IR) and Modified Release (MR) Forms of Topiramate (TPM)

Epilepsy

United States
Janey Pratt
Maternal and Child Health Research Institute

Withdrawn

Medications After Adolescent Bariatric Surgery (MAABS Protocol)

Pediatric Obesity

United States
Center for Weight Management, California
American Society of Bariatric Physicians

Completed

Long-term Phentermine Pharmacotherapy: An Investigation for Symptoms of Dependence, Cravings, or Withdrawal (PC-II)

Obesity | Phentermine Withdrawal

United States
University of California, Irvine
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

Pharmacotherapy in Conjunction With Lifestyle Counseling for Management of Weight Regain After Bariatric Surgery (PROJECT-BARI)

Obesity

United States
University of Copenhagen
R W Johnson Pharmaceutical Research Institute

Terminated

Topiramate: Long-Term Maintenance of Weight Loss Induced by Low-Calorie Diet in Obese Subjects (TOBES)

Obesity

Denmark
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Safety and Effectiveness of Topiramate on Insulin Sensitivity in Overweight or Obese Patients With Type 2 Diabetes

Obesity | Diabetes Mellitus, Type 2 | Diabetes Mellitus, Adult-Onset
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study on Efficacy and Safety of Topiramate OROS Controlled-Release in Obese, Type 2 Diabetic Subjects Managed With Diet or Metformin

Obesity | Diabetes Mellitus, Type 2 | Diabetes Mellitus, Adult-Onset
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Efficacy and Safety of Topiramate as an add-on Therapy in the Treatment of Epilepsy Patients With Lennox-Gastaut Syndrome

Epilepsy | Seizures
Janssen Pharmaceutica N.V., Belgium

Completed

The Effectiveness and Safety of Topiramate on Prevention of Chronic Migraine

Migraine
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study on Efficacy and Safety of Topiramate in the Treatment of Patients With Obesity

Obesity
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Efficacy and Safety of Topiramate in the Prevention of Migraine

Migraine | Headache | Common Migraine | Classic Migraine
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Effectiveness and Safety of Topiramate Monotherapy in Patients With Recently Diagnosed Partial-Onset Seizure

Epilepsy | Seizures | Epilepsies, Partial
Montefiore Medical Center
Ortho-McNeil Pharmaceutical

Completed

Topiramate Augmentation in the Treatment of Obsessive-Compulsive Disorder

Obsessive-compulsive Disorder

United States
Johnson & Johnson Pharmaceutical Research & Development...
Ortho-McNeil Neurologics, Inc.

Completed

A Study of the Effectiveness and Safety of Topiramate in the Treatment of Moderate to Severe Binge-eating Disorder Associated With Obesity

Obesity | Binge-Eating Disorder
Johnson & Johnson Pharmaceutical Research & Development...
Ortho-McNeil Neurologics, Inc.

Completed

A Study of the Effectiveness and Safety of Topiramate Versus Placebo for Preventing Chronic Migraine Headaches

Migraine
Johnson & Johnson Pharmaceutical Research & Development...
Ortho-McNeil Neurologics, Inc.

Completed

An Open Label Extension of a Study of Topiramate in Chronic Migraine.

Migraine
Johnson & Johnson Pharmaceutical Research & Development...

Terminated

A Study on Efficacy and Safety of Topiramate in Treatment of Obese Subjects With Dyslipidemia

Obesity | Hypertriglyceridemia | Hyperlipidemia
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Effectiveness and Safety of Topiramate in the Treatment of Children With Epilepsy

Epilepsy | Seizures | Epilepsies, Partial
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Efficacy and Safety of Topiramate Treatment in Patients With Epilepsy

Epilepsy | Seizures
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of Safety and Efficacy of Topiramate in Male Patients With Abdominal Obesity

Obesity

Search clinical trials for: Phentermine/Topiramate (Qsymia)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in India

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations